---
document_datetime: 2024-01-12 17:49:26
document_pages: 10
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/bemfola-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: bemfola-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 6.5184996
conversion_datetime: 2025-12-19 13:48:35.212113
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Bemfola

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                               | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0043              | B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking | 09/01/2024                          |                                             | PL                               |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IAIN/0042/G   | This was an application for a group of variations. B.II.g.3 - Deletion of an approved change management protocol related to the finished product A.7 - Administrative change - Deletion of                                                                                                                                                                                                                                                                                                                                                                                                                      | 08/11/2023   | n/a   |             |                     |
|---------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-------------|---------------------|
| IB/0041/G     | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place A.7 - Administrative change - Deletion of | 26/04/2023   | n/a   |             | manufacturing sites |
| IB/0040       | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                                                                                    | 16/12/2022   |       | SmPC and PL |                     |
| IB/0039       | C.I.11.z - Introduction of, or change(s) to, the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 13/10/2022   | n/a   |             |                     |

<div style=\"page-break-after: always\"></div>

|                    | obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                      |            |     |    |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----|-----------------------------------|
| IB/0038/G          | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                       | 12/07/2022 | n/a |    |                                   |
| IB/0037            | B.II.g.5.c - Implementation of changes foreseen in an approved change management protocol - For a biological/immunological medicinal product                                                                                                                                                                                      | 15/06/2022 | n/a |    |                                   |
| PSUSA/1463/ 202110 | Periodic Safety Update EU Single assessment - follitropin alfa                                                                                                                                                                                                                                                                    | 10/06/2022 | n/a |    | PRAC Recommendation - maintenance |
| N/0036             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                  | 19/05/2022 |     | PL |                                   |
| IB/0034/G          | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - | 21/12/2021 | n/a |    |                                   |

<div style=\"page-break-after: always\"></div>

|           | control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |            |     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0032   | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 13/12/2021 | n/a |
| IB/0033   | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 28/10/2021 | n/a |
| IA/0031/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 30/09/2021 | n/a |

<div style=\"page-break-after: always\"></div>

|         | test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient   |            |     | B.I.b.2.a - Change in   |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------------------|
| II/0029 | B.II.g.2 - Introduction of a post approval change management protocol related to the finished product                                                                                                                                                                                                                                                        | 28/05/2021 | n/a |                         |
| IA/0030 | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                | 17/03/2021 | n/a |                         |
| II/0027 | B.II.b.1.c - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch release/control, and secondary packaging, for biol/immunol medicinal products or pharmaceutical forms manufactured by complex manufacturing processes                                                           | 15/10/2020 | n/a |                         |
| IA/0026 | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                | 08/07/2020 | n/a |                         |
|         | This was an application for a group of variations. B.I.a.1.j - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Replacement or addition of a site where batch                                                                                                                                                        | 25/06/2020 | n/a | II/0025/G               |

<div style=\"page-break-after: always\"></div>

|                    | control/testing takes place and any of the test method at the site is a biol/immunol method B.II.b.2.b - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place for a biol/immunol product and any of the test methods at the site is a biol/immunol method   |            |     |                                   |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| IA/0024            | B.II.c.3.z - Change in source of an excipient or reagent with TSE risk - Other variation                                                                                                                                                                                                                                                                             | 13/03/2020 | n/a |                                   |
| IB/0023/G          | This was an application for a group of variations. B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                        | 05/02/2020 | n/a |                                   |
| II/0022            | B.II.g.2 - Introduction of a post approval change management protocol related to the finished product                                                                                                                                                                                                                                                                | 30/01/2020 | n/a |                                   |
| PSUSA/1463/ 201810 | Periodic Safety Update EU Single assessment - follitropin alfa                                                                                                                                                                                                                                                                                                       | 14/06/2019 | n/a | PRAC Recommendation - maintenance |
| II/0021/G          | This was an application for a group of variations. B.II.b.2.b - Change to importer, batch release arrangements and quality control testing of the FP -                                                                                                                                                                                                               | 07/03/2019 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|         | control/testing takes place for a biol/immunol product and any of the test methods at the site is a biol/immunol method B.II.b.2.b - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place for a biol/immunol product and any of the test methods at the site is a biol/immunol method                                                                                                                                                   |            |            |                                  | Replacement/addition   |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------|
| R/0019  | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 20/09/2018 | 12/11/2018 | SmPC, Annex II, Labelling and PL |                        |
| II/0016 | Update of the RMP version 2 based on the phase-3 multicentre study conducted to compare the efficacy and safety of two r-hFSH formulations in normal ovulatory women 35 to 42 years of age undergoing in vitro fertilisation (IVF) (CSR FIN3002). C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH where significant assessment is required | 14/06/2018 | n/a        |                                  |                        |
| IA/0018 | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                                                                                                                                                                                                                                                                                                                                                                   | 13/06/2018 | n/a        |                                  |                        |

<div style=\"page-break-after: always\"></div>

| N/0017      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                     | 15/05/2018   | 23/07/2018   | Labelling and PL           |                         |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------|-------------------------|
| IB/0015     | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                           | 04/12/2017   | n/a          |                            |                         |
| IA/0014     | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                        | 20/10/2017   | 23/07/2018   | Annex II and PL            |                         |
| IB/0013     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                         | 09/08/2017   | 23/07/2018   | SmPC and PL                |                         |
| IAIN/0012/G | for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 23/06/2017   | 23/07/2018   | Annex II, Labelling and PL | This was an application |
| II/0011     | B.II.b.1.c - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch                                                                                                                                                                                                                         | 23/02/2017   | n/a          |                            |                         |

<div style=\"page-break-after: always\"></div>

|                    | release/control, and secondary packaging, for biol/immunol medicinal products or pharmaceutical forms manufactured by complex manufacturing processes                                                                                                                                            |            |            |                        |                                   |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| T/0010             | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                              | 25/10/2016 | 21/11/2016 | SmPC, Labelling and PL |                                   |
| IA/0009            | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                                                                                                                   | 14/09/2016 | n/a        |                        |                                   |
| PSUSA/1463/ 201510 | Periodic Safety Update EU Single assessment - follitropin alfa                                                                                                                                                                                                                                   | 09/06/2016 | n/a        |                        | PRAC Recommendation - maintenance |
| N/0007             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                 | 04/11/2015 | 21/11/2016 | PL                     |                                   |
| IAIN/0006/G        | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier | 02/06/2015 | n/a        |                        |                                   |
| IA/0005            | B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect                                                                                                                                           | 07/04/2015 | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

|           | the product information                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |            |                                  |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|
| IA/0004   | B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier                                                                                                                                                                                                                                                                                                                   | 17/03/2015 | n/a        |                                  |
| IAIN/0003 | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                                                                                                                                                              | 23/12/2014 | n/a        |                                  |
| IB/0001/G | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes | 12/08/2014 | 03/07/2015 | SmPC, Annex II, Labelling and PL |